Skip to main content

View full-text article in PMC

. 2021 Feb 10;47(4):527–532. doi: 10.1097/DSS.0000000000002856

TABLE 1.

Change From Baseline in Lip Fullness^* at 8 Weeks After Last Injection

	HA_RK (N = 183^†/176^‡)	Control (N = 87^†/85^‡)
Upper lip
Mean (SD)	1.8 (0.98)^†	1.7 (0.90)^†
	1.8 (0.96)^‡	1.7 (0.91)^‡
95% CI mean of (control—HA_RK)	(−0.31, 0.18)^†
	(−0.32, 0.17)^‡
Lower lip
Mean (SD)	1.8 (0.98)^†	1.8 (0.85)^†
	1.8 (0.98)^‡	1.8 (0.86)^‡
95% CI mean of (control—HA_RK)	(−0.32, 0.16)^†
	(−0.30, 0.19)^‡

^*

Blinded Evaluator live assessment of upper and lower lip MLFS score.

^†

ITT.

^‡

PP.

CI, confidence interval; ITT, intention-to-treat population; MLFS, medicis lip fullness scale; PP, per protocol population.